Andrew Bowser
Andrew Bowser is a medical writer based in Brooklyn, New York.
Bladder Ca subtypes ID’d, may yield personalized therapies
Researchers from The Cancer Genome Atlas Research Network have outlined five distinct expression subtypes of muscle-invasive bladder cancer, each of which may be targetable by different treatments.
Sacral neuromodulation, botulinum show equal efficacy
In patients with refractory urgency urinary incontinence (UUI), sacral neuromodulation (InterStim) and onabotulinumtoxinA (Botox) produce similar reductions in mean daily UUI episodes, according to 24-month follow-up data on patients treated in a randomized trial.
Pair of genes may predict prostate cancer metastasis
Overexpression of a specific pair of genes might provide early warning of prostate cancer patients’ likelihood of progressing to metastatic disease.
SUI: Phase III data offer lessons for trials evaluating cell therapy
Results of one of the first randomized controlled trials evaluating cell therapy for women with stress urinary incontinence (SUI) has helped to identify clinically meaningful efficacy endpoints to refine patient selection criteria for current and future studies, according to investigator Melissa R. Kaufman, MD, PhD.
Bother, symptom severity often poorly correlated in LUTS
The correlation between patient-reported bother and symptom severity is inexact, according to conclusions of a recent retrospective multicenter study of nearly 1,200 patients referred for lower urinary tract symptoms.
Immune content linked to aggressive PCa outcomes
The level of immune response in prostate cancer may predict a patient’s response to radiation therapy, risk of disease recurrence, and survival outcomes, according to results of a recent analysis of prostate tumors.
Bladder Ca photothermal treatment yields encouraging results
Photothermal treatment with epidermal growth factor receptor-directed gold nanorods results in considerable antineoplastic activity in an early study of bladder cancer.
Quality initiative could reduce unnecessary PCa bone scans
One gentle “nudge” may be all it takes to start reducing the number of unnecessary bone scans ordered for asymptomatic men with low-risk prostate cancer, results of a recent quality improvement intervention suggest.
5-ARI may have adverse metabolic effects
Authors of a recent study say that long-term therapy with a 5-alpha-reductase inhibitor was associated with increased glucose, increased glycated hemoglobin, and altered lipid profiles.
Latest advances aid primary scalp tumor tx
New York - In patients with actinic keratoses (AK) of the scalp, treating the surrounding skin will often evoke subclinical lesions that will respond to treatment, according to Deborah F. MacFarlane, M.D., M.P.H.

Poll